Home Risk prediction of cardiovascular disease using machine learning classifiers
Article Open Access

Risk prediction of cardiovascular disease using machine learning classifiers

  • Madhumita Pal , Smita Parija EMAIL logo , Ganapati Panda , Kuldeep Dhama ORCID logo and Ranjan K. Mohapatra ORCID logo EMAIL logo
Published/Copyright: June 17, 2022

Abstract

Cardiovascular disease (CVD) makes our heart and blood vessels dysfunctional and often leads to death or physical paralysis. Therefore, early and automatic detection of CVD can save many human lives. Multiple investigations have been carried out to achieve this objective, but there is still room for improvement in performance and reliability. This study is yet another step in this direction. In this study, two reliable machine learning techniques, multi-layer perceptron (MLP), and K-nearest neighbour (K-NN) have been employed for CVD detection using publicly available University of California Irvine repository data. The performances of the models are optimally increased by removing outliers and attributes having null values. Experimental-based results demonstrate that a higher accuracy in detection of 82.47% and an area-under-the-curve value of 86.41% are obtained using the MLP model, unlike the K-NN model. Therefore, the proposed MLP model was recommended for automatic CVD detection. The proposed methodology can also be employed in detecting other diseases. In addition, the performance of the proposed model can be assessed via other standard data sets.

1 Introduction

Health is a crucial part of everyone’s life. However, owing to multiple reasons like unhealthy lifestyles, work stress, psychological strain, and external factors such as pollution, hazardous work environment, and lack of proper health services, millions of people worldwide fall prey to chronic ailments like cardiovascular diseases (CVD), which affect both the heart and blood vessels, resulting in death or disability. In recent years, it was reported that the majority of human deaths were due to CVD [1,2]. The associated conditions are hypertension, thromboembolism, hyperlipidaemia, and coronary heart disease, which culminate in heart failure. Hypertension is the primary cause of CVD [3]. In 2012, 7.4 million people were reported to have died from coronary heart disease, while 6.7 million people died from stroke [4]. The World health Organization estimates that nearly 17 million people die every year from CVDs, which accounts for approximately 31% of global deaths. Early diagnosis of CVD can potentially cure patients and save innumerable lives. Diagnosis and treatment of patients at early stages by cardiologists remain a challenge. Every traditional CVD risk-assessment model implicitly assumes each risk factor related to CVD outcome in a linear fashion. Such models have a tendency to oversimplify complex relationships, including several risk factors with non-linear interactions. Multiple risk factors should be properly incorporated, and more correlated nuances between the risk factors and outcomes should be determined. To date, no large-scale study has used routine clinical data and machine learning (ML) in prognostic CVD assessment. The goal of this study is to determine if ML can enhance cardiovascular risk prediction accuracy in population primary care at large and find out which ML algorithm result had fairly high brevity. In recent years, multiple ML-based CVD detection models have been proposed. A review of previous studies is presented to identify the research problem and objective of each study. ML helps a cardiologist to predict diseases at an early stage and treat the patient accordingly. There are many ML techniques such as support vector machines [5], artificial neural networks, decision trees [6], and K-Nearest Neighbour (K-NN) [7], each with its strengths and weaknesses. These methods have been applied in broader areas like in predicting liver [8,9], human heart (echocardiogram signals) [10,11], and skin diseases [12,13,14]. Results of each technique differ owing to several constraints. Observations from related studies reveal that there is further scope for the development of automated CVD detection using other ML models that provide improved performance. This study contains an in-depth statistical analysis of input data sets to understand the effects of data range on the CVD predictions. It includes a correlation study of categorical and continuous features of patients. In addition, data visualization and scatter plots for pairs of important features were obtained to understand the significance of the correlation between important features. These are discussed and analysed in the results section.

2 Materials and methods

The goal of this study was to determine whether or not a patient would develop CVD if a set of clinical information is available. The confusion matrix of each technique was obtained, and out of 303 occurrences in the data set, 243 (80%) were used to train the two models. To test the trained models, 60 instances were fed to know the class. This study intends to predict the likelihood of developing CVD via a computerized prediction route that can be useful to health professionals. The materials required for CVD detection are the test data of patients from publicly available standard CVD data from the UCI repository [15]. The classification algorithms used are MLP and K-NN. Generally, the method comprises training of the proposed model via respective learning algorithms using relevant input test data of patients and then validating these models based on test data of patients. Finally, performance measurements are evaluated and compared.

The following steps are carried out to predict CVD:

Step 1: Relevant CVD data set is first collected from the UCI repository.

Step 2: Data samples are pre-processed by eliminating null values, filtering for denoizing, and removing outliers present in samples.

Step 3: Attributes which are more useful in CVD forecasting are selected, and strongly correlated features are dropped.

Step 4: Two ML algorithms that are simple but effective are chosen to classify the selected features based on Figure 1.

Figure 1 
               Methodology employed in developing a CVD detection model: (a) training phase of ML models and (b) testing phase of ML models.
Figure 1

Methodology employed in developing a CVD detection model: (a) training phase of ML models and (b) testing phase of ML models.

Step 5: Various performance measures are evaluated to compare and find the better method.

2.1 Data source

The CVD data set used for developing the detection models was taken from the University of California Irvine (UCI) repository [15] and has been converted into a.csv comma-separated file. It contains 303 samples and 76 attributes. Only 13 important test attributes (age, sex, chest pain (cp), resting blood pressure (trestbps), cholesterol (chol), fasting blood sugar (fbs), resting electrocardiographic result (Restecg), maximum heart rate (thalach), exercise-induced angina (exang), ST depression (old peak), slope of peak ST segment (slope), number of major vessels (Ca), thallium stress result (thal)), and one target output (1 = patient having CVD, 0 = patient not having CVD) have been considered out of the 76 attributes to train and test the model. These are presented in Table A1. Our target value taken is whether a person has CVD (near to 1) or does not have CVD (close to 0). The data set was imbalanced as 165 patients had CVD and 138 patients were normal (Figure 2).

Figure 2 
                  Count plot of patients with CVD (1) and without CVD (0).
Figure 2

Count plot of patients with CVD (1) and without CVD (0).

The data set contains both categorical and continuous features as explained in Figures 3 and 4. The data set consists of patients between the ages of 29 and 77. Pandas, NumPy, sklearn and matplotlib python libraries were used to analyse and visualize the data. Two standard and reliable MLP and K-NN ML methods were employed for binary classification (CVD or no CVD).

Figure 3 
                  Correlation plot for CVD data set categorical features (cp: chest pain, fbs: fasting blood sugar, Restecg: resting electrocardiographic result, exang: exercise-induced angina, slope: slope of peak ST segment, Ca: number of major vessels, thal: thallium stress result, and target output (1 = patient having CVD, 0 = patient not having CVD)).
Figure 3

Correlation plot for CVD data set categorical features (cp: chest pain, fbs: fasting blood sugar, Restecg: resting electrocardiographic result, exang: exercise-induced angina, slope: slope of peak ST segment, Ca: number of major vessels, thal: thallium stress result, and target output (1 = patient having CVD, 0 = patient not having CVD)).

Figure 4 
                  Correlation plot of CVD data set continuous features.
Figure 4

Correlation plot of CVD data set continuous features.

Figure 3 shows the relationship of categorical features with the target. The plot demonstrates that females have a higher probability of developing CVD than males, and people with cp values of 1, 2, or 3 have a greater probability of contracting CVD than people with a cp value of 0. People with fbs values greater than 120 have higher chances of having heart ailment than people with fbs values less than 120. People with a Restecg value of 1 have a higher probability of heart ailment than people with values of 0 and 2. Similarly, people with an exang value of 0 are more prone to CVD than people with a value of 1. People with a slope value of 2 have a higher probability of suffering from heart ailment than people with slope values of 0 and 1. People with a ca value of 0 have a greater chance of suffering from CVD than people with ca values of 1, 2, or 3, and people with a thal value of 2 have greater chances of contracting CVD than people with values of 1 and 3. The correlation plot in Figure 4 demonstrates the range of continuous feature values for which a person should be alerted to avoid CVD problems.

2.2 Pre-processing of CVD data

There are many missing and noisy data in public data sets. These data are pre-processed to minimize distorted measurements and make predictions more reliable. The pre-process stage involves smoothing, standardization, and aggregation. During the data pre-processing phase, the correlation matrix is used to identify the correlation between different CVD data set features and shows whether the features are positively or negatively associated with one another. After pre-processing of the data set, certain categorical variables such as cp, sex, chol, and trestbps are converted into dummy variables, and the resultant data are scaled before training the ML models. All variables were scaled down using standard normal distribution, and a cross-validation K-NN value of 20 was applied. For different k values between 1 and 21, different accuracy values were obtained.

2.2.1 Scatter plot

The scatter plot (data visualization plot) is a mathematical diagram in cartesian coordinates showing the relationship between two variables of a given data set. It shows the relationship between two quantitative variables. If two variables lie on a line or curve, then they are correlated. Therefore, it objectively determines whether or not a particular cause and effect are related. In this study, various scatter plots are presented to identify potential root causes of CVD.

2.3 ML

ML is described as part of Artificial Intelligence (AI) in which a model acquires knowledge from past experience, without being explicitly programmed. Medical data are used in different ML classifiers for classification or forecasting of diseases. Supervised learning, which requires labelled input data for training the machine, is employed, and the machine learns with features called biomarkers of heart disease. Patient data are fed to the machine, and labelled outcomes are obtained. There are different ML classifiers for building data analysis models such as random forest, K-NN, and MLP. The main objective of each classifier is to build a model with exceptional disease detection capability. The classifiers used in this investigation, K-NN and MLP, have exceptional detection potentials.

2.3.1 ML classifiers

2.3.1.1 K-Nearest neighbour

K-NN is a non-parametric classifier used to determine whether a patient has CVD or not using a labelled known data set. Predictions are made based on k numbers of frequently used neighbours for a new object, and a different distance metric for finding the K-NN is used. K-NN classifies new training data points based on similarity measurements. Data points are classified by considering the majority of votes from its neighbours. This works effectively for small dimensional data sets. K-NN does not require extra training for classification if a new data point is added to the existing data set. It is an inefficient algorithm for large data sets and requires more memory space for computation and longer model testing times because of the need to compute the distance between training data set and testing data set during each test.

2.3.1.2 Multi-layer perceptron (MLP)

This is a type of artificial neural network. It functions like a human brain, such that information passes from an input node to an output node via hidden nodes in a forward direction. It contains three nodes: input node, output node, and hidden node. It is one of the powerful supervised types of classifiers for the efficient prediction of chronic diseases. An MLP is the combination of a number of neural units known as perceptrons. In this model, each layer contains a number of weights via which perceptrons are connected with each other (Figure 5). To train the feed-forward neural network, a backpropagation learning algorithm is used. Weights are adjusted to minimize errors during neural network training [16].

Figure 5 
                        Schematic diagram of MLP.
Figure 5

Schematic diagram of MLP.

Two types of activation functions are commonly used in the hidden layer: the sigmoid activation and tanh functions, given in equations (1) and (2), respectively. The weight updating rule for minimizing errors is given in equation (4).

(1) Sigmoid function , σ ( x ) = 1 1 + e x ,

(2) tanh ( x ) = 2 σ ( x ) ( 2 x ) 1 ,

(3) Mean square error = 1 p i = 1 p ( m i m ˆ ) 2 ,

where P is the number of samples, m is the actual observation, m ˆ is the predicted sample value.

(4) w j = w j α d E d w j ,

where *w j is the updated weight, w j is the previous weight, α is the learning rate (0 < α < 1) E is the error term (m m ˆ ).

2.4 Performance evaluation of models

The potential of ML algorithms is assessed using a set of performance metrics. To evaluate the parameters, a confusion matrix including the true positive (TP), false positive (FP), true negative (TN), and false negative (FN) for actual and predicted data are obtained. A confusion matrix is a table frequently used to determine performances of classifiers. Table 1 explains these parameters.

Table 1

Definition of confusion matrix parameters

Confusion matrix parameters Description
True positive Instances where we predicted yes (patient has the CVD), and it turned out to be correct
True negative Instances where a patient does not have CVD and was predicted to not have CVD
False positive Instances where a patient does not have CVD, but was predicted to have CVD
False negative Instances where a patient does not have CVD and was predicted to not have CVD

The performance of each classifier is measured using the confusion matrix and determined by five parameters: classification accuracy, sensitivity, specificity, F1-score, support, and receiver operating characteristics (ROC) – area under the curve (Table 2). The classification accuracy is used to determine the percentage of cases correctly classified and is calculated using four parameters: TP, TN, FP, and FN. The sensitivity signifies what percentage of patients with CVD is correctly identified. The specificity indicates the percentage of patients without CVD and those correctly classified. The F1-score takes the harmonic mean of a classifier’s precision and recall to create a single statistic, and is mostly used to compare the performance of two different classifiers.

Table 2

Definition of performance metrics

Performance metrices Definition/explanation
Accuracy True positive ( TP ) + True negative ( TN ) True positive ( TP ) + True negative ( TN ) + False positive ( FP ) + False negative ( FN )
Precision TP TP + FP
Recall (TP rate) TP TP + FN
F1-score TP TP TP + TP + FP + FN
Support The number of actual occurrences of a class in the provided data set
FP rate FP FP + TN
Area under the curve (AUC) AUC is an important feature of the ROC curve that measures the ability of a classifier to distinguish between classes. The greater the AUC, the better the model’s performance
ROC An ROC, or ROC curve, is a graphical representation of a binary classifier
Macro average All classes equally contribute to the final averaged metric
Weighted avg. The weight of each class’s contribution to the average

3 Results

Figures 6 and 7 show the confusion matrix of K-NN and MLP ML models, respectively. Table 3 shows the combined confusion matrix, which reveals that between the two approaches, the MLP model predicted more TPs (47 vs 24), more TNs (33 vs 21), more FPs (9 vs 6), and fewer FPs (8 vs10).

Figure 6 
               Confusion matrix for CVD prediction using the K-NN model.
Figure 6

Confusion matrix for CVD prediction using the K-NN model.

Figure 7 
               Confusion matrix for CVD prediction using the MLP model.
Figure 7

Confusion matrix for CVD prediction using the MLP model.

Table 3

Confusion matrix results of ML models

Confusion matrix parameters ML algorithms
K-NN MLP
TN 21 33
TP 24 47
FP 10 8
FN 6 9

3.1 Scatter plot between features of CVD

The plot in Figure 8 shows that as the cholesterol (chol) level of a person increases, blood pressure (trestbps) rises, which consequently increases the probability of one suffering from CVD. The plot in Figure 9 indicates that with the rise of blood pressure (trestbps), the heart rate (max heartbeat) of a person increases, which is a sign of heart ailment. Figure 10 shows that there is a strong correlation between chol and cp levels. The relationship between restecg and old peak is shown in Figure 11. In Figure 8, the orange colour signifies the people suffering from CVD while the blue colour represents people not suffering from CVD. The scatter plot in Figure 12 shows that people with heart rates above 140 between the ages of 40 and 55 are more prone to CVDs. A data visualization plot showing the correlation between individual features is shown in Figure 13.

Figure 8 
                  Data visualization plot showing correlation between features.
Figure 8

Data visualization plot showing correlation between features.

Figure 9 
                  Data visualization plot showing a correlation between resting blood pressure and maximum heart rate.
Figure 9

Data visualization plot showing a correlation between resting blood pressure and maximum heart rate.

Figure 10 
                  Data visualization plot showing a correlation between chest pain and cholesterol level.
Figure 10

Data visualization plot showing a correlation between chest pain and cholesterol level.

Figure 11 
                  Data visualization plot showing a correlation between resting electrocardiographic and old peak.
Figure 11

Data visualization plot showing a correlation between resting electrocardiographic and old peak.

Figure 12 
                  Scatter plot of maximum heart rate and age.
Figure 12

Scatter plot of maximum heart rate and age.

Figure 13 
                  Scatter plot showing correlation of CVD data set features.
Figure 13

Scatter plot showing correlation of CVD data set features.

3.2 Correlation plot between variables of the data set

The correlation matrix plot (Figure 14) shows that cp has a positive correlation with goal output; with a value of 0.43, it indicates that if a person has cp, he is likely to have CVD. Similarly, some traits are negatively connected, such as cholesterol and the target variable; their correlation value of –0.085 indicates that a person with cholesterol has suffered from CVD. It is always preferable to choose features that have positive correlations with the target variable. Features with values close to 0.9 or greater than 0.6 are substantially correlated with each other, as are features with values close to –0.3. These factors can be eliminated during data collection. For example, thalach and oldpeak have a significant relationship with a correlation value of –0.34. During data pre-processing, one of these features can be removed.

Figure 14 
                  Correlation matrix plot between features.
Figure 14

Correlation matrix plot between features.

3.3 Performance evaluation of ML models

Figure 15 shows the ROC plot of the K-NN model with an AUC score of 74%, which signifies that the model can identify 74% of CVD cases accurately.

Figure 15 
                  ROC plot of the K-NN model.
Figure 15

ROC plot of the K-NN model.

From the classification results of the K-NN model given in Table 4, performance parameters such as precision, recall, F1-score, and support values for a target output of 0 are 0.78, 0.68, 0.72, and 31, respectively. Similarly, for a target output of 1, the precision, recall, F1-score, and support values are 0.71, 0.80, 0.75, and 30, respectively. The ROC in Figure 16 shows the diagnostic capability of the MLP model, which has a diagnostic accuracy of 86.41% in CVD prediction. From the classification results, the precision, recall, F1-score, and support values for a target output of 0 are 0.79, 0.80, 0.80, and 41, respectively. However, for a target output of 1 using the MLP model, the precision, recall, F1-score, and support values are 0.85, 0.84, 0.85, and 56, respectively (Table 5).

Table 4

Classification results of the K-NN model

Parameter Precision Recall F1-score Support
0 (Without CVD) 0.78 0.68 0.72 31
1 (With CVD) 0.71 0.80 0.75 30
Accuracy NA NA 0.74 61
Macro average 0.74 0.74 0.74 61
Weighted average O.74 0.74 0.74 61
Figure 16 
                  ROC curve for the MLP model.
Figure 16

ROC curve for the MLP model.

Table 5

Classification results of the MLP model

Parameter Precision Recall F1-score Support
0 (Without CVD) 0.79 0.80 0.80 41
1 (With CVD) 0.85 0.84 0.85 56
Accuracy NA NA 0.82 97
Macro avg 0.82 0.82 0.82 97
Weighted avg 0.83 0.82 0.83 97

3.4 Comparison of results for both the models

The accuracy and AUC scores of the K-NN and MLP algorithms are presented in Table 6. The obtained accuracy (82.47%) and AUC (86.41%) values for the MLP model are higher compared to those of the K-NN model. This shows that the MLP model predicts CVD more accurately. Similarly, the AUC score for the diagnosis rate of the K-NN model is 86.21%, while that of the MLP model is 86.41%.

Table 6

Comparision of accuracy and AUC scores obtained from ML models

ML algorithms Accuracy score (%) AUC score (%)
K-NN 73.77 86.21
MLP 82.47 86.41

The comparison of results indicates that the MLP model has a higher prediction accuracy of 82.47%, followed by the K-NN model with an accuracy value of 73.77%. The accuracy comparison of these two models is presented in Fig. S1. The ROC plot also shows that the MLP algorithm has a higher AUC value (86.41%) compared to the K-NN model (86.21%). The AUC comparison for the K-NN and MLP models is shown in Fig. S2.

4 Discussion

A comparison of accuracy values from existing studies is shown in Table 7. The simulation result of the proposed work using the MLP algorithm is 82.47%, compared to 47.54% obtained by Kaur et al. [17]. The comparison of results demonstrates that the MLP algorithm provides a higher accuracy (82.47%) when compared to that of Naïve Bayes (69.11%) [18] and Decision tree (78.57%, 80.68%) [19,20]. Therefore, the proposed MLP model is more efficient in CVD prediction when compared to other ML algorithms. By increasing the number of hidden layer nodes and employing a 10-fold cross-validation technique in the MLP model, we are able to improve its accuracy.

Table 7

Performance comparision of the proposed work with existing works

Existing work Algorithms Accuracy (%) Reference
Kaur et al., 2019 MLP 47.54 [17]
Nahar et al., 2013 Naïve Bayes 69.11 [18]
Verma et al., 2016 Decision Tree 80.68 [19]
Ei-bialy et al., 2015 Decision Tree 78.54 [20]
Proposed work MLP 82.47

Regarding the literature, Alizadehsani [21] compared the performances of various well-known ML techniques for coronary artery disease detection. Latha and Jeeva [22] proposed a model for increasing the accuracy of weak classifiers by 7.26% using an ensemble model. Ahmed and co. [23] reported a heart disease risk-prediction model with a 94.9% accuracy using random forest. Beunza et al. [24] compared the performance of several ML algorithms based on the Framingham heart database to predict coronary heart disease using R-Studio and Rapid Miner and achieved the highest AUC value of 0.75 using a support vector machine method. Kim et al. [25] obtained a 0.89 AUC value using an artificial neural network to predict the survival rate of injured patients. In another study, Shah et al. [26] obtained a maximum accuracy of 90.78% when predicting heart disease using the K-NN algorithm, and Pal and Parija [27] reported a heart disease risk-prediction model with 86.9% accuracy, 90.6% sensitivity, and 82.7% specificity by using the random forest algorithm.

This study presents a comparison of two ML techniques for CVD prediction: K-NN and MLP. Between these algorithms, MLP provides better accuracy (82.47%) than K-NN with an accuracy of 73.77%. The diagnosis rate was found to be 86.41 and 86.21% for the MLP and K-NN algorithms, respectively. In the medical field, the diagnosis procedure for CVD is costly and time-consuming. The proposed approach suggests that ML can be used as a clinical tool in the detection of CVD and will be particularly useful for physicians in the event of a misdiagnosis. The constructed MLP model offers consistent accuracy compared to other techniques mentioned and is also capable of predicting other diseases. In this study, the performance of the model was improved by removing attributes with null values using an explorative data analysis method and by increasing the number of hidden layer nodes. The proposed method is expected to assist in the further development of the healthcare field. The proposed method can also be used for the classification of other chronic diseases such as breast cancer, liver disease, diabetes mellitus, and thyroid. The developed models can be applied to large data sets to predict chronic diseases using IoT and cloud computing techniques. From the above analysis, the application of ML techniques will vastly aid in preventing fatalities and supplement the efforts of doctors in fighting CVD occurrence among all patient categories of different age groups, genders, and socio-economic backgrounds. If implemented, this would be a classic case of new-age technology application for the benefit of mankind.

Acknowledgments

The authors acknowledge their respective Institutes and Universities.

  1. Funding information: No funding received.

  2. Author contributions: Conceptualization and writing – original draft: MP and SP; software, visualization, formal analysis: MP; literature search, data analysis, and interpretation: SP and RKM; writing – review and editing: KD, GP. All authors are substantially contributed toward the final version of the manuscript and agree to be accountable for its contents.

  3. Conflict of interest: There are no conflicts to declare.

  4. Data availability statement: All related data are submitted as a supplementary file.

Appendix

Figure A1 
Comparision of accuracy score of ML models.
Figure A1

Comparision of accuracy score of ML models.

Figure A2 
Comparison of AUC score of ML models.
Figure A2

Comparison of AUC score of ML models.

Table A1

Description of features of the dataset

SL NO. Features Types Description Range of features increasing the probability of heart disease
1. Age Continous Age in years NA
2. Sex Categorical Male,Female 1=male,0=female
3. Cp Categorical Chest pain type0: Typical angina1: Atypical angina2: Non-anginal pain3.Asymptomatic People with cp equl to 1, 2, 3 are more likely to have heart disease than people with cp equal to 0.
4. Trestbps Continous Resting blood pressure in mm Hg Concerning above 130-140 .
5. Chol Continous Serum cholesterol in mg/dl serum = LDL + HDL + .2 * triglyceridesAbove 200 is matter of concern
6. Fbs  Categorical Fasting blood sugar>120 mg/dl 1=true,0=false>126 mg/dl signals diabetesPeople with Fbs equal to 1 increased the probability of suffering from heart disease than people with Fbs equal to 0.
7. Restecg Categorical Resting electrocardiographic results. People with value 1 (signals non-normal heart beat, can range from mild symptoms to severe problems) are more likely to have heart disease. 0: Nothing to note1: Non normal heart beat can range from mild symptoms to severe problems2: Possible or definite left ventricular hypertrophyEnlarged heart's main pumping chamber
8. Thalach Continous Maximum heart rate achieved More than 140 are more likely to have heart disease.
9. Exang  Categorical Exercise induced angina People with value 0have more probability of suffering from heart disease than people with value 1 1=yes0=no
10. Oldpeak Continous ST depression induced by exercise relative to rest looks at stress of heart During exercise unhealthy heart will stress more
11. Slope Categorical The slope of the peak exercise ST segment 0: Upsloping: better heart rate with excercise(uncommon)1: Flatsloping: minimal change (typical healthy heart)2: Downsloping: signs of unhealthy heart
12. Ca Categorical Number of major vessels (0-3) colored by flourosopy Ca equal to 0 are more likely to have heart disease.
13. Thal Categorical Thalium stress result 1,3: normal6: fixed defect: used to be defect 7: reversable defect: no proper blood movement when exercising People with thal value equal to 2 more likely to have heart disease.
14. Target Categorical Have heart disease or not 1=yes, 0=no

References

[1] Cardiovascular diseases (CVDs). http://www.who.int/newsroom/factsheets/detail/cardiovascular-diseases-(cvds accessed on 30/9/2018.Search in Google Scholar

[2] Patel B, Sengupta P. Machine learning for predicting cardiac events: what does the future hold? Expert Rev Cardiovasc Ther. 2020;18(2):77–84.10.1080/14779072.2020.1732208Search in Google Scholar PubMed PubMed Central

[3] Baharvand-Ahmadi B, Bahmani M, Zargaran A. A brief report of Rhazes manuscripts in the field of cardiology and cardiovascular diseases. Int J Cardiol. 2016;207:190–1.10.1016/j.ijcard.2016.01.021Search in Google Scholar PubMed

[4] Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLOS ONE. 2017;12(4):e0174944.10.1371/journal.pone.0174944Search in Google Scholar PubMed PubMed Central

[5] Yan H, Ye Q, Zhang T, Yu D-J, Yuan X, Xu Y, et al. Least squares twin bounded support vector machines based on L1-norm distance metric for classification. Pattern Recogn. 2018;74:434–47.10.1016/j.patcog.2017.09.035Search in Google Scholar

[6] Jaworski M, Duda P, Rutkowski L. New splitting criteria for decision trees in stationary data streams. IEEE Trans Neural Netw Learn Syst. 2018;29:2516–29.10.1109/TNNLS.2017.2698204Search in Google Scholar PubMed

[7] Zhang S, Cheng D, Deng Z, Zong M, Deng X. A novel K-NN algorithm with data driven k parameter computation. Pattern Recogn Lett. 2018;109:44–54.10.1016/j.patrec.2017.09.036Search in Google Scholar

[8] Abdar M, Zomorodi-Moghadam M, Das R, Ting IH. Performance analysis of classification algorithms on early detection of liver disease. Expert Syst Appl. 2017;67:239–51.10.1016/j.eswa.2016.08.065Search in Google Scholar

[9] Abdar M, Yen NY, Hung JC-S. Improving the diagnosis of liver disease using multilayer perceptron neural network and boosted decision trees. J Med Biol Eng. 2017;10:1–13.10.1007/s40846-017-0360-zSearch in Google Scholar

[10] Pławiak P. Novel genetic ensembles of classifiers applied to myocardium dysfunction recognition based on ECG signals, Swarm. Evol Comput. 2018;39:192–208.10.1016/j.swevo.2017.10.002Search in Google Scholar

[11] Pławiak P. Novel methodology of cardiac health recognition based on ECG signals and evolutionary-neural system. Expert Syst Appl. 2018;92:334–49.10.1016/j.eswa.2017.09.022Search in Google Scholar

[12] Khozeimeh F, Alizadehsani R, Roshanzamir M, Khosravi A, Layegh P, Nahavandi S. An expert system for selecting wart treatment method. Comput Biol Med. 2017;81:167–75.10.1016/j.compbiomed.2017.01.001Search in Google Scholar PubMed

[13] Khozeimeh F, Azad FJ, Oskouei YM, Jafari M, Tehranian S, Alizadehsani R, et al. Intralesional immunotherapy compared to cryotherapy in the treatment of warts. Int J Dermatology. 2017;56:474–8.10.1111/ijd.13535Search in Google Scholar PubMed

[14] Alizadehsani R, Abdar M, Jalali SMJ, Roshanzamir M, Khosravi A, Nahavandi S. Comparing the performance of feature selection algorithms for wart treatment selection. Proc. Int. Workshop Future Technol; 2018. p. 6–18.Search in Google Scholar

[15] https://archive.ics.uci.edu/ml/datasets/Heart+Disease.Search in Google Scholar

[16] Wu C, Yeh W, Hsu WD, Islam M, Nguyen P, Poly TN, et al. Prediction of fatty liver disease using machine learning algorithms. Computer Methods Prog Biomed. 2019;170:23–9.10.1016/j.cmpb.2018.12.032Search in Google Scholar PubMed

[17] Kaur P, Kumar R, Kumar M. A healthcare monitoring system using random forest and internet of things (IoT). Multimed Tools Appl. 2019;78:19905–16.10.1007/s11042-019-7327-8Search in Google Scholar

[18] Nahar J, Imam T, Tickle KS, Chen YPP. Computational intelligence for heart disease diagnosis: a medical knowledge driven approach. Expert Syst Appl. 2013;40(1):96–104.10.1016/j.eswa.2012.07.032Search in Google Scholar

[19] Verma L, Srivastava S, Negi PC. A hybrid data mining model to predict coronary artery disease cases using non-invasive clinical data. J Med Syst. 2016;40(7):1–7.10.1007/s10916-016-0536-zSearch in Google Scholar PubMed

[20] EI-Bialy R, Salamay MA, Karam OH, Khalifa ME. Feature analysis of coronary artery heart disease data sets. Proc Comput Sci. 2015;65:459–68.10.1016/j.procs.2015.09.132Search in Google Scholar

[21] Alizadehsani R, Abdar M, Roshanzamir M, Khosravi A, Kebria PM, Khozeimeh F, et al. Machine learning-based coronary artery disease diagnosis: A comprehensive review. Computers Biol Med. 2019;111:103346.10.1016/j.compbiomed.2019.103346Search in Google Scholar PubMed

[22] Latha CBC, Jeeva SC. Improving the accuracy of prediction of heart disease risk based on ensemble classification techniques. 2019;16:100203.10.1016/j.imu.2019.100203Search in Google Scholar

[23] Ahmed H, Younis EMG, Hendawi A, Ali AA. Heart disease identification from patients’ social posts, machine learning solution on spark. Future Gener Computer Syst. 2020;111:714–22. 10.1016/j.future.2019.09.056.Search in Google Scholar

[24] Beunza J-J, Puertas E, García-Ovejero E, Villalba G, Condes E, Koleva G, et al. Comparison of machine learning algorithms for clinical event prediction (risk of coronary heart disease). J Biomed Inform. 2019;97:103257.10.1016/j.jbi.2019.103257Search in Google Scholar PubMed

[25] Kim D, You S, So S, Lee J, Yook S, Jang DP. A data-driven artificial intelligence model for remote triage in the prehospital environment. PLoS ONE. 2018;13(10):e0206006.10.1371/journal.pone.0206006Search in Google Scholar PubMed PubMed Central

[26] Shah D, Patel S, Bharti SK. Heart Disease Prediction using Machine Learning Techniques. SN Computer Sci. 2020;1:345–6.10.1007/s42979-020-00365-ySearch in Google Scholar

[27] Pal M, Parija S. Prediction of Heart Diseases using Random Forest. J Physics: Conf Ser. 2021;1817:012009. 10.1088/1742-6596/1817/1/012009.Search in Google Scholar

Received: 2021-02-11
Revised: 2022-05-14
Accepted: 2022-05-23
Published Online: 2022-06-17

© 2022 Madhumita Pal et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. AMBRA1 attenuates the proliferation of uveal melanoma cells
  3. A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma
  4. Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis
  5. Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis
  6. Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4
  7. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
  8. Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?
  9. The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma
  10. Gene signature to predict prognostic survival of hepatocellular carcinoma
  11. Effects of miRNA-199a-5p on cell proliferation and apoptosis of uterine leiomyoma by targeting MED12
  12. Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
  13. Is there any effect on imprinted genes H19, PEG3, and SNRPN during AOA?
  14. Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
  15. Pericentric inversion of chromosome 6 and male fertility problems
  16. Staple line reinforcement with nebulized cyanoacrylate glue in laparoscopic sleeve gastrectomy: A propensity score-matched study
  17. Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
  18. Expression of DNM3 is associated with good outcome in colorectal cancer
  19. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
  20. CRRT influences PICCO measurements in febrile critically ill patients
  21. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis
  22. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
  23. circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
  24. Prognostic value of nicotinamide N-methyltransferase in human cancers: Evidence from a meta-analysis and database validation
  25. GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma
  26. A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors
  27. Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer
  28. Association between preventable risk factors and metabolic syndrome
  29. miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6
  30. Cardiac contractility modulation ameliorates myocardial metabolic remodeling in a rabbit model of chronic heart failure through activation of AMPK and PPAR-α pathway
  31. Quercitrin protects human bronchial epithelial cells from oxidative damage
  32. Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2
  33. circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury
  34. Sonoclot’s usefulness in prediction of cardiopulmonary arrest prognosis: A proof of concept study
  35. Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation
  36. Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma
  37. LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway
  38. Cx43 upregulation in HUVECs under stretch via TGF-β1 and cytoskeletal network
  39. Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey
  40. Histopathologic findings on removed stomach after sleeve gastrectomy. Do they influence the outcome?
  41. Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma
  42. Optimal diagnosis of the skin cancer using a hybrid deep neural network and grasshopper optimization algorithm
  43. miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells
  44. Clinical value of SIRT1 as a prognostic biomarker in esophageal squamous cell carcinoma, a systematic meta-analysis
  45. circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8
  46. miR-22-5p regulates the self-renewal of spermatogonial stem cells by targeting EZH2
  47. hsa-miR-340-5p inhibits epithelial–mesenchymal transition in endometriosis by targeting MAP3K2 and inactivating MAPK/ERK signaling
  48. circ_0085296 inhibits the biological functions of trophoblast cells to promote the progression of preeclampsia via the miR-942-5p/THBS2 network
  49. TCD hemodynamics findings in the subacute phase of anterior circulation stroke patients treated with mechanical thrombectomy
  50. Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid
  51. Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
  52. circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis
  53. Human amniotic fluid as a source of stem cells
  54. lncRNA NONRATT013819.2 promotes transforming growth factor-β1-induced myofibroblastic transition of hepatic stellate cells by miR24-3p/lox
  55. NORAD modulates miR-30c-5p-LDHA to protect lung endothelial cells damage
  56. Idiopathic pulmonary fibrosis telemedicine management during COVID-19 outbreak
  57. Risk factors for adverse drug reactions associated with clopidogrel therapy
  58. Serum zinc associated with immunity and inflammatory markers in Covid-19
  59. The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies
  60. LncRNA expression in idiopathic achalasia: New insight and preliminary exploration into pathogenesis
  61. Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway
  62. Moscatilin suppresses the inflammation from macrophages and T cells
  63. Zoledronate promotes ECM degradation and apoptosis via Wnt/β-catenin
  64. Epithelial-mesenchymal transition-related genes in coronary artery disease
  65. The effect evaluation of traditional vaginal surgery and transvaginal mesh surgery for severe pelvic organ prolapse: 5 years follow-up
  66. Repeated partial splenic artery embolization for hypersplenism improves platelet count
  67. Low expression of miR-27b in serum exosomes of non-small cell lung cancer facilitates its progression by affecting EGFR
  68. Exosomal hsa_circ_0000519 modulates the NSCLC cell growth and metastasis via miR-1258/RHOV axis
  69. miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1
  70. The effect of tranexamic acid on the reduction of intraoperative and postoperative blood loss and thromboembolic risk in patients with hip fracture
  71. Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
  72. Artemisinin protects against cerebral ischemia and reperfusion injury via inhibiting the NF-κB pathway
  73. A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
  74. Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization
  75. MicroRNA 322-5p reduced neuronal inflammation via the TLR4/TRAF6/NF-κB axis in a rat epilepsy model
  76. miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis
  77. Clinical characteristics of pneumonia patients of long course of illness infected with SARS-CoV-2
  78. circRNF20 aggravates the malignancy of retinoblastoma depending on the regulation of miR-132-3p/PAX6 axis
  79. Linezolid for resistant Gram-positive bacterial infections in children under 12 years: A meta-analysis
  80. Rack1 regulates pro-inflammatory cytokines by NF-κB in diabetic nephropathy
  81. Comprehensive analysis of molecular mechanism and a novel prognostic signature based on small nuclear RNA biomarkers in gastric cancer patients
  82. Smog and risk of maternal and fetal birth outcomes: A retrospective study in Baoding, China
  83. Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1
  84. β2-Adrenergic receptor expression in subchondral bone of patients with varus knee osteoarthritis
  85. Possible impact of COVID-19 pandemic and lockdown on suicide behavior among patients in Southeast Serbia
  86. In vitro antimicrobial activity of ozonated oil in liposome eyedrop against multidrug-resistant bacteria
  87. Potential biomarkers for inflammatory response in acute lung injury
  88. A low serum uric acid concentration predicts a poor prognosis in adult patients with candidemia
  89. Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
  90. ALKBH5 inhibits TNF-α-induced apoptosis of HUVECs through Bcl-2 pathway
  91. Risk prediction of cardiovascular disease using machine learning classifiers
  92. Value of ultrasonography parameters in diagnosing polycystic ovary syndrome
  93. Bioinformatics analysis reveals three key genes and four survival genes associated with youth-onset NSCLC
  94. Identification of autophagy-related biomarkers in patients with pulmonary arterial hypertension based on bioinformatics analysis
  95. Protective effects of glaucocalyxin A on the airway of asthmatic mice
  96. Overexpression of miR-100-5p inhibits papillary thyroid cancer progression via targeting FZD8
  97. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation
  98. Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
  99. Identification of osteoporosis based on gene biomarkers using support vector machine
  100. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis
  101. miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3
  102. Association of ST-T changes with all-cause mortality among patients with peripheral T-cell lymphomas
  103. LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma
  104. The perinatal factors that influence the excretion of fecal calprotectin in premature-born children
  105. Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study
  106. Does the use of 3D-printed cones give a chance to postpone the use of megaprostheses in patients with large bone defects in the knee joint?
  107. lncRNA HAGLR modulates myocardial ischemia–reperfusion injury in mice through regulating miR-133a-3p/MAPK1 axis
  108. Protective effect of ghrelin on intestinal I/R injury in rats
  109. In vivo knee kinematics of an innovative prosthesis design
  110. Relationship between the height of fibular head and the incidence and severity of knee osteoarthritis
  111. lncRNA WT1-AS attenuates hypoxia/ischemia-induced neuronal injury during cerebral ischemic stroke via miR-186-5p/XIAP axis
  112. Correlation of cardiac troponin T and APACHE III score with all-cause in-hospital mortality in critically ill patients with acute pulmonary embolism
  113. LncRNA LINC01857 reduces metastasis and angiogenesis in breast cancer cells via regulating miR-2052/CENPQ axis
  114. Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer
  115. SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
  116. Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose
  117. Treatment and outcomes of mechanical complications of acute myocardial infarction during the Covid-19 era: A comparison with the pre-Covid-19 period. A systematic review and meta-analysis
  118. Neonatal stroke surveillance study protocol in the United Kingdom and Republic of Ireland
  119. Oncogenic role of TWF2 in human tumors: A pan-cancer analysis
  120. Mean corpuscular hemoglobin predicts the length of hospital stay independent of severity classification in patients with acute pancreatitis
  121. Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure
  122. TGF-β1 upregulates Sar1a expression and induces procollagen-I secretion in hypertrophic scarring fibroblasts
  123. Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
  124. NK-cell dysfunction of acute myeloid leukemia in relation to the renin–angiotensin system and neurotransmitter genes
  125. The effect of dilution with glucose and prolonged injection time on dexamethasone-induced perineal irritation – A randomized controlled trial
  126. miR-146-5p restrains calcification of vascular smooth muscle cells by suppressing TRAF6
  127. Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells
  128. lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
  129. Noninvasive diagnosis of AIH/PBC overlap syndrome based on prediction models
  130. lncRNA FAM230B is highly expressed in colorectal cancer and suppresses the maturation of miR-1182 to increase cell proliferation
  131. circ-LIMK1 regulates cisplatin resistance in lung adenocarcinoma by targeting miR-512-5p/HMGA1 axis
  132. LncRNA SNHG3 promoted cell proliferation, migration, and metastasis of esophageal squamous cell carcinoma via regulating miR-151a-3p/PFN2 axis
  133. Risk perception and affective state on work exhaustion in obstetrics during the COVID-19 pandemic
  134. lncRNA-AC130710/miR-129-5p/mGluR1 axis promote migration and invasion by activating PKCα-MAPK signal pathway in melanoma
  135. SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53
  136. Xylooligosaccharides and aerobic training regulate metabolism and behavior in rats with streptozotocin-induced type 1 diabetes
  137. Serpin family A member 1 is an oncogene in glioma and its translation is enhanced by NAD(P)H quinone dehydrogenase 1 through RNA-binding activity
  138. Silencing of CPSF7 inhibits the proliferation, migration, and invasion of lung adenocarcinoma cells by blocking the AKT/mTOR signaling pathway
  139. Ultrasound-guided lumbar plexus block versus transversus abdominis plane block for analgesia in children with hip dislocation: A double-blind, randomized trial
  140. Relationship of plasma MBP and 8-oxo-dG with brain damage in preterm
  141. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma
  142. Delayed femoral vein ligation reduces operative time and blood loss during hip disarticulation in patients with extremity tumors
  143. The expression of ASAP3 and NOTCH3 and the clinicopathological characteristics of adult glioma patients
  144. Longitudinal analysis of factors related to Helicobacter pylori infection in Chinese adults
  145. HOXA10 enhances cell proliferation and suppresses apoptosis in esophageal cancer via activating p38/ERK signaling pathway
  146. Meta-analysis of early-life antibiotic use and allergic rhinitis
  147. Marital status and its correlation with age, race, and gender in prognosis of tonsil squamous cell carcinomas
  148. HPV16 E6E7 up-regulates KIF2A expression by activating JNK/c-Jun signal, is beneficial to migration and invasion of cervical cancer cells
  149. Amino acid profiles in the tissue and serum of patients with liver cancer
  150. Pain in critically ill COVID-19 patients: An Italian retrospective study
  151. Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
  152. Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
  153. Long non-coding RNAs LINC00689 inhibits the apoptosis of human nucleus pulposus cells via miR-3127-5p/ATG7 axis-mediated autophagy
  154. The relationship between oxygen therapy, drug therapy, and COVID-19 mortality
  155. Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: Trial mimicking with retrospective data
  156. SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
  157. The role of Shunaoxin pills in the treatment of chronic cerebral hypoperfusion and its main pharmacodynamic components
  158. TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
  159. Associations between morphokinetic parameters of temporary-arrest embryos and the clinical prognosis in FET cycles
  160. Long noncoding RNA WT1-AS regulates trophoblast proliferation, migration, and invasion via the microRNA-186-5p/CADM2 axis
  161. The incidence of bronchiectasis in chronic obstructive pulmonary disease
  162. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
  163. Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway
  164. Comparison of hospitalized patients with severe pneumonia caused by COVID-19 and influenza A (H7N9 and H1N1): A retrospective study from a designated hospital
  165. lncRNA ZFAS1 promotes intervertebral disc degeneration by upregulating AAK1
  166. Pathological characteristics of liver injury induced by N,N-dimethylformamide: From humans to animal models
  167. lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB
  168. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis
  169. Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer
  170. MGST1 alleviates the oxidative stress of trophoblast cells induced by hypoxia/reoxygenation and promotes cell proliferation, migration, and invasion by activating the PI3K/AKT/mTOR pathway
  171. Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1
  172. circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis
  173. EphA3 targeted by miR-3666 contributes to melanoma malignancy via activating ERK1/2 and p38 MAPK pathways
  174. Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
  175. miRNA-130a-3p targets sphingosine-1-phosphate receptor 1 to activate the microglial and astrocytes and to promote neural injury under the high glucose condition
  176. Review Articles
  177. Current management of cancer pain in Italy: Expert opinion paper
  178. Hearing loss and brain disorders: A review of multiple pathologies
  179. The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
  180. Amyotrophic lateral sclerosis and delayed onset muscle soreness in light of the impaired blink and stretch reflexes – watch out for Piezo2
  181. Interleukin-35 in autoimmune dermatoses: Current concepts
  182. Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
  183. Advantages of ketamine in pediatric anesthesia
  184. Congenital adrenal hyperplasia. Role of dentist in early diagnosis
  185. Migraine management: Non-pharmacological points for patients and health care professionals
  186. Atherogenic index of plasma and coronary artery disease: A systematic review
  187. Physiological and modulatory role of thioredoxins in the cellular function
  188. Case Reports
  189. Intrauterine Bakri balloon tamponade plus cervical cerclage for the prevention and treatment of postpartum haemorrhage in late pregnancy complicated with acute aortic dissection: Case series
  190. A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice
  191. Unusual neurological manifestations of bilateral medial medullary infarction: A case report
  192. Atypical symptoms of malignant hyperthermia: A rare causative mutation in the RYR1 gene
  193. A case report of dermatomyositis with the missed diagnosis of non-small cell lung cancer and concurrence of pulmonary tuberculosis
  194. A rare case of endometrial polyp complicated with uterine inversion: A case report and clinical management
  195. Spontaneous rupturing of splenic artery aneurysm: Another reason for fatal syncope and shock (Case report and literature review)
  196. Fungal infection mimicking COVID-19 infection – A case report
  197. Concurrent aspergillosis and cystic pulmonary metastases in a patient with tongue squamous cell carcinoma
  198. Paraganglioma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation
  199. Lineage switch from lymphoma to myeloid neoplasms: First case series from a single institution
  200. Trismus during tracheal extubation as a complication of general anaesthesia – A case report
  201. Simultaneous treatment of a pubovesical fistula and lymph node metastasis secondary to multimodal treatment for prostate cancer: Case report and review of the literature
  202. Two case reports of skin vasculitis following the COVID-19 immunization
  203. Ureteroiliac fistula after oncological surgery: Case report and review of the literature
  204. Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report
  205. Huge mucinous cystic neoplasms with adhesion to the left colon: A case report and literature review
  206. Commentary
  207. Commentary on “Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma”
  208. Rapid Communication
  209. COVID-19 fear, post-traumatic stress, growth, and the role of resilience
  210. Erratum
  211. Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
  212. Erratum to “Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study”
  213. Erratum to “lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2”
  214. Retraction
  215. Expression and role of ABIN1 in sepsis: In vitro and in vivo studies
  216. Retraction to “miR-519d downregulates LEP expression to inhibit preeclampsia development”
  217. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part II
  218. Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Downloaded on 3.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2022-0508/html
Scroll to top button